000 01462 a2200409 4500
005 20250513142241.0
264 0 _c19980518
008 199805s 0 0 eng d
022 _a0022-3042
024 7 _a10.1046/j.1471-4159.1998.70051819.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBohn, L M
245 0 0 _aEvidence for kappa- and mu-opioid receptor expression in C6 glioma cells.
_h[electronic resource]
260 _bJournal of neurochemistry
_cMay 1998
300 _a1819-25 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnalgesics
_xmetabolism
650 0 4 _aAnalgesics, Opioid
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBenzeneacetamides
650 0 4 _aBinding, Competitive
650 0 4 _aDesipramine
_xpharmacology
650 0 4 _aGlioma
_xmetabolism
650 0 4 _aMorphine
_xmetabolism
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPyrrolidines
_xmetabolism
650 0 4 _aRats
650 0 4 _aReceptors, Opioid, kappa
_xmetabolism
650 0 4 _aReceptors, Opioid, mu
_xmetabolism
650 0 4 _aTranscription, Genetic
650 0 4 _aTumor Cells, Cultured
_xdrug effects
650 0 4 _abeta-Endorphin
_xmetabolism
700 1 _aBelcheva, M M
700 1 _aCoscia, C J
773 0 _tJournal of neurochemistry
_gvol. 70
_gno. 5
_gp. 1819-25
856 4 0 _uhttps://doi.org/10.1046/j.1471-4159.1998.70051819.x
_zAvailable from publisher's website
999 _c9539277
_d9539277